Agreement of swept-source and spectral-domain optical coherence-tomography retinal thickness measurements in neovascular age-related macular degeneration

Daren Hanumunthadu,1 Tomas Ilginis,1 Kamaljit S Balaggan,1,2 Praveen J Patel1 On behalf of the DOCS team 1NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and University College London Institute of Ophthalmology, London, 2Wolverhampton and Midland Counties Eye Infirmar...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hanumunthadu D, Ilginis T, Balaggan KS, Patel PJ
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/4d77971655f44569893259991fa25edd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4d77971655f44569893259991fa25edd
record_format dspace
spelling oai:doaj.org-article:4d77971655f44569893259991fa25edd2021-12-02T00:38:50ZAgreement of swept-source and spectral-domain optical coherence-tomography retinal thickness measurements in neovascular age-related macular degeneration1177-5483https://doaj.org/article/4d77971655f44569893259991fa25edd2017-11-01T00:00:00Zhttps://www.dovepress.com/agreement-of-swept-source-and-spectral-domain-optical-coherence-tomogr-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Daren Hanumunthadu,1 Tomas Ilginis,1 Kamaljit S Balaggan,1,2 Praveen J Patel1 On behalf of the DOCS team 1NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and University College London Institute of Ophthalmology, London, 2Wolverhampton and Midland Counties Eye Infirmary, Wolverhampton, UKChanges in macular thickness measurements in neovascular age-related macular degeneration (nAMD) are thought to reflect disease activity, and can be used to guide treatment with antiangiogenic agents.1 Both spectral-domain optical coherence tomography (SD-OCT) and the more recently introduced swept-source optical coherence tomography (SS-OCT) have onboard segmentation algorithms that deliver automated retinal thickness measurements. Agreement between OCT derived macular thickness measurements is critical for monitoring of patients if these modalities are to be used interchangeably. This prospective cross-sectional study sought to determine the limits of agreement between SD-OCT (Spectralis; Heidelberg Engineering) and SS-OCT (DRI OCT-1 Atlantis; Topcon Medical Systems) in patients with nAMD.Hanumunthadu DIlginis TBalaggan KSPatel PJDove Medical PressarticleAge related macular degenerationOptical coherence tomographyAgreementOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 11, Pp 2121-2123 (2017)
institution DOAJ
collection DOAJ
language EN
topic Age related macular degeneration
Optical coherence tomography
Agreement
Ophthalmology
RE1-994
spellingShingle Age related macular degeneration
Optical coherence tomography
Agreement
Ophthalmology
RE1-994
Hanumunthadu D
Ilginis T
Balaggan KS
Patel PJ
Agreement of swept-source and spectral-domain optical coherence-tomography retinal thickness measurements in neovascular age-related macular degeneration
description Daren Hanumunthadu,1 Tomas Ilginis,1 Kamaljit S Balaggan,1,2 Praveen J Patel1 On behalf of the DOCS team 1NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and University College London Institute of Ophthalmology, London, 2Wolverhampton and Midland Counties Eye Infirmary, Wolverhampton, UKChanges in macular thickness measurements in neovascular age-related macular degeneration (nAMD) are thought to reflect disease activity, and can be used to guide treatment with antiangiogenic agents.1 Both spectral-domain optical coherence tomography (SD-OCT) and the more recently introduced swept-source optical coherence tomography (SS-OCT) have onboard segmentation algorithms that deliver automated retinal thickness measurements. Agreement between OCT derived macular thickness measurements is critical for monitoring of patients if these modalities are to be used interchangeably. This prospective cross-sectional study sought to determine the limits of agreement between SD-OCT (Spectralis; Heidelberg Engineering) and SS-OCT (DRI OCT-1 Atlantis; Topcon Medical Systems) in patients with nAMD.
format article
author Hanumunthadu D
Ilginis T
Balaggan KS
Patel PJ
author_facet Hanumunthadu D
Ilginis T
Balaggan KS
Patel PJ
author_sort Hanumunthadu D
title Agreement of swept-source and spectral-domain optical coherence-tomography retinal thickness measurements in neovascular age-related macular degeneration
title_short Agreement of swept-source and spectral-domain optical coherence-tomography retinal thickness measurements in neovascular age-related macular degeneration
title_full Agreement of swept-source and spectral-domain optical coherence-tomography retinal thickness measurements in neovascular age-related macular degeneration
title_fullStr Agreement of swept-source and spectral-domain optical coherence-tomography retinal thickness measurements in neovascular age-related macular degeneration
title_full_unstemmed Agreement of swept-source and spectral-domain optical coherence-tomography retinal thickness measurements in neovascular age-related macular degeneration
title_sort agreement of swept-source and spectral-domain optical coherence-tomography retinal thickness measurements in neovascular age-related macular degeneration
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/4d77971655f44569893259991fa25edd
work_keys_str_mv AT hanumunthadud agreementofsweptsourceandspectraldomainopticalcoherencetomographyretinalthicknessmeasurementsinneovascularagerelatedmaculardegeneration
AT ilginist agreementofsweptsourceandspectraldomainopticalcoherencetomographyretinalthicknessmeasurementsinneovascularagerelatedmaculardegeneration
AT balagganks agreementofsweptsourceandspectraldomainopticalcoherencetomographyretinalthicknessmeasurementsinneovascularagerelatedmaculardegeneration
AT patelpj agreementofsweptsourceandspectraldomainopticalcoherencetomographyretinalthicknessmeasurementsinneovascularagerelatedmaculardegeneration
_version_ 1718403552861224960